InsidersTradesSigma
Follow the 株式会社リプロセル stock price and the full insider trade history of the company, a listed equity based in Japan. Shares are quoted on JP JP, under the supervision of EDINET (Japan FSA). Market capitalisation: €12.7bn. The latest transaction was filed on 7 August 2026 (Holding update). Among the most active insiders: Morgan Stanley MUFG Securities Co., Ltd.. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
11 of 11 declarations
Reprocell Inc. is a Japanese company listed on the XTKS market, specializing in the development of cell reprogramming technologies. It focuses on applications in regenerative medicine and biotechnology.